Cover Letter for Submission of New Drug Gretamine for Emergency-Use FDA Authorization, Submitted by High Tide Therapeutics Ltd. on February 21, 2028
donb.substack.com
To whom it may concern: Four years ago, researchers at Yale University first characterized the mental health epidemic of chronic climate dysphoria—a disorder defined by severe anxiety symptoms in response to chronic exposure to the inexorable impacts of climate change. In the four years since, we at High Tide Therapeutics have been hard at work on a new medication to address this crisis. Today, we humbly submit for your review the result of these efforts: Gretamine.
Cover Letter for Submission of New Drug Gretamine for Emergency-Use FDA Authorization, Submitted by High Tide Therapeutics Ltd. on February 21, 2028
Cover Letter for Submission of New Drug…
Cover Letter for Submission of New Drug Gretamine for Emergency-Use FDA Authorization, Submitted by High Tide Therapeutics Ltd. on February 21, 2028
To whom it may concern: Four years ago, researchers at Yale University first characterized the mental health epidemic of chronic climate dysphoria—a disorder defined by severe anxiety symptoms in response to chronic exposure to the inexorable impacts of climate change. In the four years since, we at High Tide Therapeutics have been hard at work on a new medication to address this crisis. Today, we humbly submit for your review the result of these efforts: Gretamine.